Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 6 studies | 27% ± 18% |
Insufficient scRNA-seq data for expression of TGFB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 7394.44 | 245 / 245 | 97% | 33.85 | 487 / 502 |
breast | 98% | 2549.02 | 450 / 459 | 98% | 53.67 | 1100 / 1118 |
brain | 96% | 1908.15 | 2535 / 2642 | 99% | 19.14 | 697 / 705 |
pancreas | 100% | 2649.34 | 328 / 328 | 92% | 41.54 | 164 / 178 |
lung | 99% | 3667.39 | 570 / 578 | 87% | 15.51 | 1000 / 1155 |
uterus | 99% | 3856.68 | 169 / 170 | 78% | 18.62 | 356 / 459 |
thymus | 99% | 2052.28 | 646 / 653 | 77% | 11.49 | 467 / 605 |
adrenal gland | 100% | 2001.52 | 258 / 258 | 66% | 9.18 | 152 / 230 |
bladder | 100% | 3639.24 | 21 / 21 | 56% | 10.21 | 281 / 504 |
kidney | 87% | 1777.89 | 77 / 89 | 65% | 9.55 | 587 / 901 |
stomach | 99% | 1635.85 | 357 / 359 | 52% | 8.07 | 148 / 286 |
ovary | 99% | 1226.17 | 179 / 180 | 47% | 6.99 | 203 / 430 |
esophagus | 88% | 1302.10 | 1266 / 1445 | 54% | 7.54 | 99 / 183 |
skin | 61% | 520.26 | 1102 / 1809 | 69% | 11.58 | 324 / 472 |
intestine | 83% | 1326.21 | 798 / 966 | 42% | 7.05 | 220 / 527 |
liver | 76% | 1541.14 | 171 / 226 | 38% | 5.87 | 153 / 406 |
blood vessel | 100% | 3894.69 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 3148.34 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2371.78 | 855 / 861 | 0% | 0 | 0 / 0 |
adipose | 97% | 2482.52 | 1166 / 1204 | 0% | 0 | 0 / 0 |
spleen | 88% | 811.32 | 212 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 16.05 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 55% | 6.12 | 16 / 29 |
eye | 0% | 0 | 0 / 0 | 20% | 1.75 | 16 / 80 |
peripheral blood | 1% | 3.43 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030879 | Biological process | mammary gland development |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0048286 | Biological process | lung alveolus development |
GO_0042476 | Biological process | odontogenesis |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0001701 | Biological process | in utero embryonic development |
GO_0043627 | Biological process | response to estrogen |
GO_1904706 | Biological process | negative regulation of vascular associated smooth muscle cell proliferation |
GO_0051496 | Biological process | positive regulation of stress fiber assembly |
GO_0062009 | Biological process | secondary palate development |
GO_0048839 | Biological process | inner ear development |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0007565 | Biological process | female pregnancy |
GO_0042704 | Biological process | uterine wall breakdown |
GO_0045216 | Biological process | cell-cell junction organization |
GO_0050714 | Biological process | positive regulation of protein secretion |
GO_0060364 | Biological process | frontal suture morphogenesis |
GO_0051491 | Biological process | positive regulation of filopodium assembly |
GO_0032967 | Biological process | positive regulation of collagen biosynthetic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0070483 | Biological process | detection of hypoxia |
GO_0001666 | Biological process | response to hypoxia |
GO_0048702 | Biological process | embryonic neurocranium morphogenesis |
GO_0048565 | Biological process | digestive tract development |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0010936 | Biological process | negative regulation of macrophage cytokine production |
GO_1905005 | Biological process | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
GO_0034616 | Biological process | response to laminar fluid shear stress |
GO_0032570 | Biological process | response to progesterone |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0060325 | Biological process | face morphogenesis |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_1905075 | Biological process | positive regulation of tight junction disassembly |
GO_0007435 | Biological process | salivary gland morphogenesis |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0043025 | Cellular component | neuronal cell body |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0009986 | Cellular component | cell surface |
GO_0030315 | Cellular component | T-tubule |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0034714 | Molecular function | type III transforming growth factor beta receptor binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0034713 | Molecular function | type I transforming growth factor beta receptor binding |
GO_0050431 | Molecular function | transforming growth factor beta binding |
GO_0005114 | Molecular function | type II transforming growth factor beta receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | TGFB3 |
Protein name | Transforming growth factor beta 3 Transforming growth factor beta Transforming growth factor beta-3 proprotein [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-3 (TGF-beta-3)] Transforming growth factor-beta 3 |
Synonyms | hCG_20489 |
Description | FUNCTION: Transforming growth factor beta-3 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains, which constitute the regulatory and active subunit of TGF-beta-3, respectively. . FUNCTION: Transforming growth factor beta-3 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains, which constitute the regulatory and active subunit of TGF-beta-3, respectively. .; FUNCTION: [Latency-associated peptide]: Required to maintain the Transforming growth factor beta-3 (TGF-beta-3) chain in a latent state during storage in extracellular matrix (By similarity). Associates non-covalently with TGF-beta-3 and regulates its activation via interaction with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-3 (By similarity). Interaction with integrins results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-3 (By similarity). .; FUNCTION: Transforming growth factor beta-3: Multifunctional protein that regulates embryogenesis and cell differentiation and is required in various processes such as secondary palate development (By similarity). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains remain non-covalently linked rendering TGF-beta-3 inactive during storage in extracellular matrix (By similarity). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1 and LRRC32/GARP that control activation of TGF-beta-3 and maintain it in a latent state during storage in extracellular milieus (By similarity). TGF-beta-3 is released from LAP by integrins: integrin-binding results in distortion of the LAP chain and subsequent release of the active TGF-beta-3 (By similarity). Once activated following release of LAP, TGF-beta-3 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (By similarity). . |
Accessions | ENST00000555193.1 A0A6Q8PGK5 ENST00000238682.8 [P10600-1] Q6LDJ6 Q6TV16 A5YM40 Q6TV15 ENST00000556285.1 [P10600-2] ENST00000556674.2 [P10600-1] Q6TV14 P10600 |